• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    14.67 Up 0.57(4.08%) 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 7,000   -   5,000  
    Cost of Revenue -   -   -  
    Gross Profit 7,000   -   5,000  
    Operating Expenses
    Research Development32,387  19,369  26,209  
    Selling General and Administrative21,696  7,710  7,540  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (47,083) (27,079) (28,749)
    Income from Continuing Operations
    Total Other Income/Expenses Net351  4,358  380  
    Earnings Before Interest And Taxes(46,732)(25,360)(28,369)
    Interest Expense -   -   -  
    Income Before Tax(46,732)(25,360)(28,369)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(46,732)(25,360)(28,369)
    Non-recurring Events
    Discontinued Operations -   -  246  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (46,732) (22,721) (28,123)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (46,732) (22,721) (28,123)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.